Ambrisentan

In the US, Ambrisentan (ambrisentan systemic) is a member of the drug class agents for pulmonary hypertension and is used to treat Pulmonary Arterial Hypertension.

US matches:

• Ambrisentan

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C02KX02

CAS registry number (Chemical Abstracts Service)

0177036-94-1

Chemical Formula

C22-H22-N2-O4

Molecular Weight

378

Therapeutic Categories

Antihypertensive agent

Vasoconstrictor

Endothelin antagonist

Chemical Name

(+)-(2S)-2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid (WHO)

Foreign Names

• Ambrisentanum (Latin)
• Ambrisentan (German)
• Ambrisentan (French)
• Ambrisentán (Spanish)

Generic Names

• Ambrisentan (OS: BAN)
• BSF 208075 (IS)
• LU 208075 (IS)

Brand Names

• Letairis
  Gilead, United States



• Volibris
  Glaxo Group, Austria; Glaxo SmithKline, Spain; GlaxoGroup, Netherlands; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.